Skip to content

Japanese prospective observational study of 3D-OCT guided bifurcation PCI

Japanese prospective observational study of 3D-OCT guided bifurcation PCI - Japanese 3D-OCT Bifurcation Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026759
Enrollment
600
Registered
2017-04-01
Start date
2018-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Sponsors

Society of 3D-OCT(office: Osaka Saiseikai Nakatsu Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patient with a de novo lesion in which stent will be implanted 2) Patient who has a side branch with visually confirmed luminal diameter of 2 mm or more 3) Age 20 years or older

Exclusion criteria

Exclusion criteria: 1) Patient who has a stent restenosis lesion in which stent will be implanted 2) Patient with cardiogenic shock 3) Patient with a STEMI and CTO lesion 4) Patient who is considered PCI not applicable 5) Patient whom physician in charge of the study determined not applicable

Design outcomes

Primary

MeasureTime frame
Bifurcation area restenosis within a year after PCI in the Optimal group with side branch dilatation, Suboptimal group and the group with no side branch dilatation. (50% or more stenosis progression from immediately after the clinical trial due to nature of coronary angiography)

Secondary

MeasureTime frame
Rate of major adverse cardiovascular events within 3 years after PCI. Cardiac death, non-cardiac death, myocardial infarction, stent thrombosis, target lesion revascularization (TLR), target vessel revascularization (TVR), and renal dysfunction. <Exploratory parameter> An exploratory study on bifurcation stenting using 3D OCT imaging guide *Jailed strut pattern, success rate of optimal cell re-crossing, PCI procedure time, contrast usage, and fluoroscopy time.

Countries

Japan

Contacts

Public ContactRyoji Nagoshi

Osaka Saiseikai Nakatsu Hospital Cardiology

ryoji754@gmail.com06-6372-0333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026